APC anti-mouse CD25 Antibody
- 产品名称：
- APC anti-mouse CD25 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 101909
- 产品应用：
- 101909
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- IL-2-dependent BALB/c mouse helper T-cell clone HT-2
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Red Laser (633 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: in vitro blocking of IL-2 binding to low- and high-affinity receptors1,2, and immunohistochemical staining of acetone-fixed frozen sections. 3C7 antibody recognizes different epitope of PC61 antibody (Cat. No. 102002). The Ultra-LEAF?Purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 101925 and 101926).
- Application References
(PubMed link indicates BioLegend citation) -
- Ortega RG, et al. 1984. J. Immunol. 133:1970. (Block)
- Moreau JL, et al. 1987. Eur. J. Immunol. 17:929. (Block)
- Product Citations
-
- Laura C Burzynski et al. 2019. Immunity. 50(4):1033-1042 . PubMed
- Li X, et al. 2022. Nat Commun. 13:2794. PubMed
- Li X, et al. 2019. Mol Med Rep. 19:4195. PubMed
- Rosalia R, et al. 2013. Immunobiology. 218:851. PubMed
- Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed
- Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
- Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
- Gorczynski RM, et al. 2017. Immunology. 150:418. PubMed
- Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
- Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
- Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
- Shi R, et al. 2022. Theranostics. 12:875. PubMed
- Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
- Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
- Sharma M, et al. 2020. Circ Res. 127:335. PubMed
- Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
- Mushaben E, et al. 2011. J Immunol. 187:5756. PubMed
- Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
- Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
- Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
- Li J, et al. 2022. Nat Commun. 13:4032. PubMed
- Zeng Q, et al. 2022. iScience. 25:105151. PubMed
- Gubin MM, et al. 2018. Cell. 175:1014. PubMed
- Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
- Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
- Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
- He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
- Kiuchi M, et al. 2021. J Exp Med. 218:. PubMed
- Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed
- Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
- Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
- MaruYama T, et al. 2015. J Leukoc Biol. 98: 385-393. PubMed
- Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
- Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
- Singh KS, et al. 2020. Nat Commun. 0.786805556. PubMed
- Yoshida H, et al. 2019. Cell. 176:897. PubMed
- Satoh–Takayama N, et al. 2020. Immunity. 52(4):635-649. PubMed
- Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
- Sharma M, et al. 2019. Immunometabolism. 1. PubMed
- Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
- Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
- Lee S, et al. 2021. Autophagy. Online ahead of print. PubMed
- Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
- Scott G, et al. 2009. J Immunol. 182:7509. PubMed
- Tsai S, et al. 2018. Cell Metab. 28:922. PubMed
- RRID
- AB_961208 (BioLegend Cat. No. 101909) AB_2280288 (BioLegend Cat. No. 101910)
- Structure
- Forms high affinity IL-2R with IL-2Rβ (CD122) and IL-2Rγ (CD132), 55 kD
- Distribution
-
Activated T cells and B cells, thymocyte subset, pre-B cells, T regulatory cells
- Function
- IL-2 receptor, signal transduction
- Ligand/Receptor
- IL-2
- Cell Type
- B cells, T cells, Tregs
- Biology Area
- Immunology
- Molecular Family
- CD Molecules, Cytokine/Chemokine Receptors
- Antigen References
-
1. Taniguchi T, et al. 1993. Cell 73:5.
2. Waldmann TA. 1991. J. Biol. Chem. 266:2681.
3. Read S, et al. 2000. J. Exp. Med. 192:295.
4. Lowenthal JW, et al. 1985. J. Immunol. 135:3988.
- Gene ID
- 16184 View all products for this Gene ID
- UniProt
- View information about CD25 on UniProt.org
